Bath, United Kingdom · Founded 2012 · Privately Held (backing)
Developer of a thermostability technology designed to improve the stability and accessibility of temperature-sensitive vaccines. Stablepharma is based in Bath, United Kingdom and was founded in 2012. Its last reported valuation was $72.2 million in Dec 2024. It has raised $10.5 million.
Last reported valuation
$72.2M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—
Cap table — not yet on record
Stablepharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stablepharma with a free account
·Watch Stablepharma: the Monday email on marks, rounds and moves
